Market Research Logo

Heart Valve Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Heart Valve Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024
The report on global heart valve devices market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global heart valve devices market to grow with a CAGR of 8.8% over the forecast period of 2018-2024. The study on heart valve devices market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
Global heart valve devices market is showing a positive trend of development around the globe. There are many factors which are helping to boost this market such as increasing instances of obesity and unhealthy lifestyle, mental tension, rising geriatric population, increase in heart valve related disease are causing various cardiac diseases and pathological disorders in human being. Heart valve devices markets are regulated by the governments for price, subsidies. Whenever any manufacturer wants to introduce the modern heart valve devices in market, government regulation comes as the obstacle for this. Hence, governments’ regulation is the major restraint factor for the growth of this market. In addition, the increasing demand for minimally invasive procedures and continued product modifications by leveraging the latest technologies developments have brought about more effective heart valve devices.
On the basis of region, the global heart valve devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America dominates the global heart valve devices market because of the greater uptake of technologically superior products and continuous upgradation of heart devices with most advance technology. Asia Pacific region is expected to grow at the highest CAGR during the forecast period of 2018-2024 because of high occurrence of heart valve diseases and an improving healthcare infrastructure.
Key Developments:-
Admedus commences animal trials for heart valve device in July 2018
Admedus Ltd has commenced animal trials by completing the first successful live implantation of its unique single-piece aortic heart valve. This represents a key milestone in the development of its patented transcatheter aortic valve replacement (TAVR) project. Admedus has partnered with a European lab to examine the safety and feasibility of the unique valve in live sheep. The first single-piece valve was implanted this month, officially marking the start of the trial period, which is expected to last for around five months.
Hancock Jaffe Laboratories to Conduct Analysis for FDA Submission Package for Bioprosthetic Heart Valve in July 2018
Hancock Jaffe Laboratories, Inc, a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, announced that it has initiated an analysis of its bioprosthetic heart valve in order to determine what additional testing is needed in order to submit an Investigational Device Extension (IDE) application to the United States Food and Drug Administration (FDA).
Admedus signs exclusive distribution agreement in Italy for its unique heart tissue product in July 2018
Admedus Ltd has signed an exclusive distribution agreement with Medical Instruments S.p.A. to market and distribute its clinically-superior ADAPT® technology in Italy. Under the agreement, Medical Instruments would initially distribute Admedus’ non-toxic and non-calcifying flagship ADAPT® bio-scaffold CardioCel®. The bio-scaffold is used to repair congenital heart deformities and more complex heart defects. It is also used to reconstruct dysfunctional heart valves and valve leaflets.


The report on heart valve devices market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global heart valve devices market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global heart valve devices market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global heart valve devices market is segmented on the basis of type and end-use.

Global heart Valve Devices Market by Type
Mechanical Heart Valves
Biological Heart Valves
Transcatheter Heart Valves
Global heart Valve Devices Market by End-use
Hospitals
Ambulatory Surgical Centers

Company Profiles
JenaValve Technology, Inc.
Edward Lifesciences Corporation
CryoLife, Inc.
Boston Scientific Corporation
Abbott
Medtronic
SYMETIS
Neovasc, Inc.
Sorin Group (LivaNova PLC)
Micro Interventional Devices, Inc.

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of heart valve devices market.
2. Complete coverage of all the segments in heart valve devices market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global heart valve devices market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on heart valve devices market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global heart valve devices market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Heart Valve Devices Market Highlights
2.2. Heart Valve Devices Market Projection
2.3. Heart Valve Devices Market Regional Highlights
3. Global Heart Valve Devices Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Type
3.4.2. IGR-Growth Matrix Analysis by End-user
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value chain Heart Valve Devices Market
4. Heart Valve Devices Market macro indicator analysis
5. Global Heart Valve Devices Market by Type
5.1. Mechanical Heart Valves
5.1.1. Aortic Valves
5.1.2. Mitral Valves
5.2. Biological Heart Valves
5.2.1. Aortic Valves
5.2.2. Mitral Valves
5.2.3. Pulmonary Valves
5.2.4. Tricuspid Valves
5.3. Transcatheter Heart Valves
5.3.1. Aortic Valves
5.3.2. Mitral Valves
5.3.3. Pulmonary Valves
6. Global Heart Valve Devices Market by End-use
6.1. Hospitals
6.2. Ambulatory Surgical Centers
7. Global Heart Valve Devices Market by Region 2018-2024
7.1. North America
7.1.1. North America Heart Valve Devices Market by Type
7.1.2. North America Heart Valve Devices Market by End-user
7.1.3. North America Heart Valve Devices Market by Country
7.2. Europe
7.2.1. Europe Heart Valve Devices Market by Type
7.2.2. Europe Heart Valve Devices Market by End-user
7.2.3. Europe Heart Valve Devices Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Heart Valve Devices Market by Type
7.3.2. Asia-Pacific Heart Valve Devices Market by End-user
7.3.3. Asia-Pacific Heart Valve Devices Market by Country
7.4. RoW
7.4.1. RoW Heart Valve Devices Market by Type
7.4.2. RoW Heart Valve Devices Market by End-user
7.4.3. RoW Heart Valve Devices Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Heart Valve Devices Market
8.2. Companies Profiles
8.2.1. Jenavalve Technology, Inc.
8.2.1.1. Overview
8.2.1.2. Company Snapshot
8.2.1.3. Financial Snapshot
8.2.1.4. Product portfolio
8.2.1.5. Recent developments
8.2.2. Edward Lifesciences Corporation
8.2.2.1. Overview
8.2.2.2. Company Snapshot
8.2.2.3. Financial Snapshot
8.2.2.4. Product portfolio
8.2.2.5. Recent developments
8.2.3. Cryolife, Inc.
8.2.3.1. Overview
8.2.3.2. Company Snapshot
8.2.3.3. Financial Snapshot
8.2.3.4. Product portfolio
8.2.3.5. Recent developments
8.2.4. Boston Scientific Corporation
8.2.4.1. Overview
8.2.4.2. Company Snapshot
8.2.4.3. Financial Snapshot
8.2.4.4. Product portfolio
8.2.4.5. Recent developments
8.2.5. Abbott
8.2.5.1. Overview
8.2.5.2. Company Snapshot
8.2.5.3. Financial Snapshot
8.2.5.4. Product portfolio
8.2.5.5. Recent developments
8.2.6. medtronic
8.2.6.1. Overview
8.2.6.2. Company Snapshot
8.2.6.3. Financial Snapshot
8.2.6.4. Product portfolio
8.2.6.5. Recent developments
8.2.7. Symetis
8.2.7.1. Overview
8.2.7.2. Company Snapshot
8.2.7.3. Financial Snapshot
8.2.7.4. Product portfolio
8.2.7.5. Recent developments
8.2.8. Neovasc, Inc.
8.2.8.1. Overview
8.2.8.2. Company Snapshot
8.2.8.3. Financial Snapshot
8.2.8.4. Product portfolio
8.2.8.5. Recent developments
8.2.9. Sorin Group (livanova Plc)
8.2.9.1. Overview
8.2.9.2. Company Snapshot
8.2.9.3. Financial Snapshot
8.2.9.4. Product portfolio
8.2.9.5. Recent developments
8.2.10. Micro Interventional Devices, Inc.
8.2.10.1. Overview
8.2.10.2. Company Snapshot
8.2.10.3. Financial Snapshot
8.2.10.4. Product portfolio
8.2.10.5. Recent developments
9. Appendix
9.1. Primary research findings and questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report